Back
Information filed with the U.S. Securities and Exchange Commission
Company Announcement
28 July 2025
Attached are documents filed with the U.S. Securities and Exchange Commission.
Attachments
07282025-6K
07282025-F3
Contact us
FAQ
Íslenska
Company
For investors
Biosimilars
Careers
Newsroom